Infections as a major preventable cause of human cancer

Journal of Internal Medicine

Volumn 248, Issue 3, 2000, Pages 171-183

  Kuper, H ^a   Adami, H O ^a,b   Trichopoulos, D ^a,b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Aetiology; Cancer; Infections; Public health

Indexed keywords

CANCER PREVENTION; CARCINOGENESIS; CELL TRANSFORMATION; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE DEFICIENCY; INFECTION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW; SCHISTOSOMIASIS; WART VIRUS;

ANIMALS; CLONORCHIASIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; NEOPLASMS; PRIMARY PREVENTION; SCHISTOSOMIASIS; VIRUS DISEASES;

EID: 0033831517     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00742.x     Document Type: Review

References (105)

1. Introduction
2. Viral carcinogenesis: Revelation of molecular mechanisms and etiology of human disease
3. Cancer and infection: Estimates of the attributable fraction in 1990
4. Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis
5. Ideas in pathology. Pivotal role of increased cell proliferation in human carcinogenesis
6. Overview of the epidemiology of immunodeficiency-associated cancers
7. Viral oncogenesis
8. The environment and disease: Association or causation?
9. Global programme for control of hepatitis B infection
10. Hepatitis B: An important public health issue
11. Hepatitis B virus and liver cancer: Unanswered questions
12. The influence of age on the development of the hepatitis B carrier state
13. Hepatitis B and C viruses in the etiology of hepatocellular carcinoma: A study in Greece using third generation assays
14. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma
15. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma
16. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
17. Hepatitis B virus and hepatocellular carcinoma
18. Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA
19. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer
20. Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level
21. Inhibition of hepatitis-B-virus core promoter by p53: Implications for carcinogenesis in hepatocytes
22. Hepatitis B virus X protein interferes with cellular DNA repair
23. Hepatitis B viruses and hepatocellular carcinoma
24. Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma
25. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study
26. The natural history of neoplastic development: The relation of experimental models to human cancers
27. Genetic heterogeneity and properties of hepatitis C virus
28. Quasispecies in viral persistence and pathogenesis of hepatitis C virus
29. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
30. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium
31. Hepatitis viruses: Their role in human cancer
32. Hepatitis C virus and hepatocellular carcinoma
33. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan
34. Detection of hepatitis C virus RNA sequences in hepatocellular carcinoma and its precursors by microdissection polymerase chain reaction
35. HCV-associated liver cancer without cirrhosis
36. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein
37. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype
38. Suppression of apoptotic cell death by hepatitis C virus core protein
39. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor
40. Functional and physical interaction between p53 and BZLF1: Implications for Epstein-Barr virus latency
41. The Epstein-Barr virus immediate-early gene product, BRLF1. interacts with the retinoblastoma protein during the viral lytic cycle
42. IARC, Infections with Epstein-Barr virus, human herpes viruses IARC monographs on the evaluation of carcinogenic risks to humans
43. The pathogenesis of Burkitt's lymphoma
44. The Epstein-Barr virus and malignancy: Molecular evidence
45. Viruses, cancer. Causal associations
46. Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma
47. Deregulation of the proto-oncogene c-myc through t(8:22) translocation in Burkitt's lymphoma
48. Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma
49. Epstein-Barr virus-specific antibody titers in seven Alaskan natives before and after diagnosis of nasopharyngeal carcinoma
50. Epidemiology of Hodgkin's disease
51. Epidemiology of Hodgkin's disease
52. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis
53. A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings
54. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis
55. Genomic aberrations of human papillomavirus recovered from cervical cancers
56. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells
57. Association of human papillomavirus types 16 and 18, E6 proteins with p53
58. Interaction of the human papillomavirus type 16. E6 oncoprotein with wild-type and mutant human p53 proteins
59. Inhibition of p53 DNA binding by human papillomavirus E6 proteins
60. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18
61. Tergaonkar V. Pleiotropic effects of human papillomavirus type 16. E6 oncogene expression in human epithelial cell lines
62. Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint
63. Telomerase activation by the E6 gene product of human papillomavirus type 16
64. Accumulation of human papillomavirus type 16. E7 protein bypasses G1 arrest induced by serum deprivation and by the cell cycle inhibitor p21
65. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product
66. Regions of human papillomavirus type 16. E7 oncoprotein required for immortalization of human keratinocytes
67. The human papillomavirus type 16. E7 gene product interacts with and transactivates the AP1 family of transcription factors
68. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2
69. Sexual transmission and the natural history of human herpesvirus 8 infection
70. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
71. Kaposi's Sarcoma, and Related Lympho-proliferative Disorders
72. Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection?
73. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection
74. Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group
75. Kaposi's sarcoma: A result of the interplay among inflammatory cytokines. Angiogenic factors and viral agents
76. The epidemiology of HTLV-I infection
77. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: An initial report from the Miyazaki Cohort Study
78. Retroviruses - Human immunodeficiency virus
79. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I
80. Adult T-cell leukemia: Clinical and hematologic features of 16 cases
81. Epidemiology of human T-cell leukemia/lymphoma virus
82. Molecular biology of human T-cell leukemia virus associated with adult T-cell leukemia
83. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells
84. Human Immunodeficiency Virus Infection and Cancer
85. EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer
86. H. pylori, the most common bacterial infection in Africa: A random serological study
87. How is Helicobacter pylori transmitted?
88. Is Helicobacter pylori Infection a Cause of Gastric Neoplasia?
89. The decline in the incidence of stomach cancer in Sweden 1960-84: A birth cohort phenomenon
90. Helicobacter pylori infection and gastric lymphoma
91. Factors related to the occurence of gastrric adenocarcinoma subtypes. Doctoral Dissertation
92. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk
93. H. pylori virulence factors
94. Ultrastructure of hepatocyte abnormalities in perimetastatic areas
95. Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients
96. Possible mechanisms of alteration in the capacities of carcinogen metabolizing enzymes during schistosomiasis and their role in bladder cancer induction
97. Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma
98. Sirisinha S. Ultrastructural characteristics of liver fluke associated human cholangiocarcinoma cell lines
99. Liver fluke infection and cholangiocarcinoma: Model of endogenous nitric oxide and extragastric nitrosation in human carcino-genesis
100. Promotion of cholangiocarcinogenesis in the hamster liver by bile duct ligation after dimethylnitrosamine initiation